0000950170-24-002134.txt : 20240104 0000950170-24-002134.hdr.sgml : 20240104 20240104183520 ACCESSION NUMBER: 0000950170-24-002134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell Bradley L CENTRAL INDEX KEY: 0001400971 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 24513781 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (215) 921-7600 MAIL ADDRESS: STREET 1: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC DATE OF NAME CHANGE: 20020729 4 1 ownership.xml 4 X0508 4 2024-01-02 0001178879 AMICUS THERAPEUTICS, INC. FOLD 0001400971 Campbell Bradley L 47 HULFISH STREET PRINCETON NJ 08542 true true false false President and CEO true Common Stock 2024-01-02 4 A false 153810 0.0 A 963257 D Common Stock 2024-01-02 4 F false 15452 14.24 D 947805 D Common Stock 2024-01-02 4 M false 7500 8.61 A 955305 D Common Stock 2024-01-02 4 S false 7500 14.2358 D 947805 D Common Stock 2024-01-02 4 M false 8333 12.28 A 956138 D Common Stock 2024-01-02 4 S false 8333 14.2339 D 947805 D Common Stock 2024-01-03 4 F false 41474 13.53 D 906331 D Stock Options (right to buy) 14.24 2024-01-02 4 A false 265517 0.0 A 2034-01-02 Common Stock 265517 265517 D Stock Options (right to buy) 8.61 2024-01-02 4 M false 7500 0 D 2025-01-02 Common Stock 7500 82500 D Stock Options (right to buy) 12.28 2024-01-02 4 M false 8333 0.0 D 2025-06-01 Common Stock 8333 91667 D Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 2, 2025 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock. This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.96 to $14.49 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.95 to $14.52 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter. All of the options were fully vested and exercisable as of the transaction date. All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2023. /s/ Christian Formica, Attorney-in-Fact 2024-01-04